DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $14,567,040 | +279.8% | 60,696 | +298.9% | 2.52% | +202.8% |
Q1 2023 | $3,835,041 | -62.4% | 15,216 | -60.4% | 0.83% | -69.3% |
Q4 2022 | $10,190,270 | -25.6% | 38,393 | -27.6% | 2.71% | -30.3% |
Q3 2022 | $13,691,000 | +40.4% | 53,006 | +37.8% | 3.89% | +8.4% |
Q2 2022 | $9,752,000 | -10.1% | 38,466 | +4.0% | 3.59% | +13.1% |
Q1 2022 | $10,845,000 | -44.0% | 36,972 | -37.2% | 3.17% | -25.7% |
Q4 2021 | $19,361,000 | +40.3% | 58,847 | +29.8% | 4.27% | +22.4% |
Q3 2021 | $13,798,000 | -7.9% | 45,324 | -18.8% | 3.49% | +6.6% |
Q2 2021 | $14,981,000 | +2.4% | 55,824 | -14.1% | 3.28% | -3.5% |
Q1 2021 | $14,627,000 | +38.1% | 64,985 | +36.3% | 3.40% | +25.1% |
Q4 2020 | $10,593,000 | -24.3% | 47,687 | -26.6% | 2.71% | -26.8% |
Q3 2020 | $13,998,000 | +58.3% | 65,008 | +30.0% | 3.71% | +48.8% |
Q2 2020 | $8,842,000 | – | 50,000 | – | 2.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |